Incidence and characterization of cytomegalovirus resistance mutations among pediatric solid organ transplant patients who received valganciclovir prophylaxis.

Incidence and characterization of cytomegalovirus resistance mutations among pediatric solid organ transplant patients who received valganciclovir prophylaxis.

Item
http://www.wikidata.org/entity/Q43170288
Antiviral drug resistance of human cytomegalovirus.Recombinant phenotyping of cytomegalovirus UL97 kinase sequence variants for ganciclovir resistance.The biology of cytomegalovirus drug resistanceGanciclovir-resistant cytomegalovirus (CMV) retinitis in a patient with wild-type CMV in her plasmaEmergence of antiviral resistance during oral valganciclovir treatment of an infant with congenital cytomegalovirus (CMV) infection.Ganciclovir-resistant cytomegalovirus infections among lung transplant recipients are associated with poor outcomes despite treatment with foscarnet-containing regimens.Cytomegalovirus risk, prevention, and management in pediatric solid organ transplantation.Clinical aspects of cytomegalovirus antiviral resistance in solid organ transplant recipients.Clinical pharmacokinetics and pharmacodynamics of ganciclovir and valganciclovir in children with cytomegalovirus infection.Recombinant phenotyping of cytomegalovirus UL54 mutations that emerged during cell passages in the presence of either ganciclovir or foscarnet.Antiviral Drug- and Multidrug Resistance in Cytomegalovirus Infected SCT Patients.Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art.Cytomegalovirus UL97 kinase catalytic domain mutations that confer multidrug resistance.Tolerability of up to 200 days of prophylaxis with valganciclovir oral solution and/or film-coated tablets in pediatric kidney transplant recipients at risk of cytomegalovirus disease.The time course of development and impact from viral resistance against ganciclovir in cytomegalovirus infection.
P2860

Incidence and characterization of cytomegalovirus resistance mutations among pediatric solid organ transplant patients who received valganciclovir prophylaxis.

Item
http://www.wikidata.org/entity/Q43170288
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Incidence and characterization ...... ed valganciclovir prophylaxis.
@en
Incidence and characterization ...... ed valganciclovir prophylaxis.
@nl
type
label
Incidence and characterization ...... ed valganciclovir prophylaxis.
@en
Incidence and characterization ...... ed valganciclovir prophylaxis.
@nl
prefLabel
Incidence and characterization ...... ed valganciclovir prophylaxis.
@en
Incidence and characterization ...... ed valganciclovir prophylaxis.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Incidence and characterization ...... ed valganciclovir prophylaxis.
@en
P2093
P304
P31
P356
P433
P478
P577
P698
P921